Item Type | Name |
Concept
|
Leukemia, Lymphoid
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
Concept
|
Myeloid-Lymphoid Leukemia Protein
|
Academic Article
|
Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line.
|
Academic Article
|
Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
|
Academic Article
|
Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia.
|
Academic Article
|
Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
|
Academic Article
|
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.
|
Academic Article
|
ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
|
Academic Article
|
The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
|
Academic Article
|
The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
|
Academic Article
|
Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.
|
Academic Article
|
Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?
|
Academic Article
|
Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.
|
Academic Article
|
Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization.
|
Academic Article
|
DNA rearrangements and altered transcripts of the MLL gene in a human T-ALL cell line Karpas 45 with a t(X;11) (q13;q23) translocation.
|
Academic Article
|
The human MLL gene: nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing.
|
Academic Article
|
Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
|
Academic Article
|
Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival.
|
Academic Article
|
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
|
Academic Article
|
Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis.
|
Academic Article
|
EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
|
Academic Article
|
MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
|
Academic Article
|
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
|
Academic Article
|
Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia.
|
Academic Article
|
Paradoxical Effects of MLL Paralogs in MLL-Rearranged Leukemia.
|
Academic Article
|
The full transforming capacity of MLL-Af4 is interlinked with lymphoid lineage commitment.
|
Academic Article
|
Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
|
Academic Article
|
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).
|
Academic Article
|
Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study.
|
Academic Article
|
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.
|